Purpose: To clone the putative tumor suppressor gene(s) in a refined region at 9p21-22 undergoing loss of heterozygosity in nasopharyngeal carcinoma (NPC). Methods: We systematically screened the expression patterns of 25 novel ESTs (expressed sequence tags) in a minimal common deleted region of 9p21-22 in NPC. One of these ESTs was found down-regulated in NPC. Subsequently, the corresponding gene sequence of this EST was established by cDNA cloning and RACE (rapid amplification of cDNA end) procedures. Furthermore, a mouse homologue of this gene was identified. The expression of this gene was examined using Northern blot or reverse transcription-polymerase chain reaction (RT-PCR) in various human and mouse tissues. A limited screen for mutation of coding sequence of this novel human gene was undertaken using RT-PCR and direct sequencing analysis. Results: A novel gene was cloned. This gene is a new member of the UBA domain family, so we named it UBAP1 for ubiquitin-associated protein 1 (HUGO Gene Nomenclature Committee-approved symbol). Northern blot and RT-PCR analysis demonstrate a ubiquitous pattern of gene expression in human and mouse tissues. The direct sequencing analysis of the coding region of hUBAP1 following RT-PCR failed to reveal any mutations in a preliminary screen of NPC cell line HNE1 and primary nasopharyngeal carcinoma samples. Conclusions: We cloned a novel gene UBAP1, which is highly conserved between human and mouse. Clearly, as a novel member of UBA domain protein family and taking its map location into account, a more extensive analysis is essential to establish whether subtle mutations are present in nasopharyngeal carcinomas.
|Original language||English (US)|
|Number of pages||6|
|Journal||Journal of Cancer Research and Clinical Oncology|
|State||Published - 2001|
Bibliographical noteFunding Information:
Acknowledgements This work is supported by: (1) State 863 High-Tech R&D Program Grants: No. 102-10-01-05; (2) State 863 High-Tech R&D Program Grants: No. Z19-01-01-03; (3) State Key Basic Research Program, Fundamental Investigation on Human Carcinogenesis: No. G1998051008; and (4) Chinese Medicine Board of New York, Inc.: No. 96-655.
- Chromosome 9p21-22
- Cloning and expression
- Nasopharyngeal carcinoma
- UBA domain